LAB VALUES
TestAbbreviationValue
MUST KNOW NCLEX LAB VALUES
C OM P L E T E B L O O D C O U N T ( C B C )
H e m o g l o b i n H e m a t o c r i t W h i t e B l o o d C e l l P l a t e l e t C o u n t H g b H c t W B C P L T
M a l e : 1 4 - 1 8 g / d L
F e m a l e : 1 2 - 1 6 g / d L
M a l e : 4 2 - 5 2 %
F e m a l e : 3 7 - 4 7 %
- - 1 0 m m 3
- 5 0 - 4 0 0 m m 3
C O A G U L A T I O N P A N E L ( C O A G S )
P r o t h r o m b i n T i m e International Normalized Ratio Partial thromboplastin time Activated partial thromboplastin time P T I N R P T T
A P T T
- 0 - 1 2 s e c
- . 9 - 1 . 2 s e c o n d s
- 0 - 3 0 s e c
- 0 - 4 0 s e c
B A S I C M E T A B O L I C P A N E L ( B M P )
G l u c o s e S o d i u m P o t a s s i u m C r e a t i n i n e B l o o d U r e a N i t r o g e n G l u N a K n / a B U N
- 0 - 1 1 0 m g / d L
- 3 5 - 1 4 5 m E q / L
- . 5 - 5 m E q / L
- . 6 - 1 . 2 m g / d L
- 0 - 2 0 m g / d L
A R T E R I A L B L O O D G A S ( A B G )
p H C a r b o n D i o x i d e P a r t i a l P r e s s u r e O x y g e n B i c a r b o n a t e O x y g e n s a t u r a t i o n n / a
P C O 2
P O 2
H C O 3
S a O 2
7 . 3 5 - 7 . 4 5
- 5 - 4 5 m m H g
- 0 - 1 0 0 m m H g
- 2 - 2 8 m E q / L
9 5 - 1 0 0 %
M I S C E L L A N E O U S
C h o l e s t e r o l G l y c o s y l a t e d H e m o g l o b i n n / a H g b A 1 C < 2 0 0 m g / d L 5.7-6.4% Prediabetes 6.5% Diabetes Mellitus Dx < 7% treatment goal for diabetics
LAB VALUES
TestAbbreviationValue
ADDITIONAL LAB VALUES FOR REFERENCE
C O M P L E T E B L O O D C O U N T ( C B C )
R e d B l o o d C e l l R B C
M a l e : 4 . 7 - 6 . 1 m m 3
F e m a l e : 4 . 2 - 5 . 4 m m 3
C O A G U L A T I O N P A N E L ( C O A G S )
D-Dimern / a< 5 0 0 n g / m L
C O M P L E T E M E T A B O L I C P A N E L ( C M P )
C a l c i u m C h l o r i d e C a r b o n D i o x i d e v e n o u s M a g n e s i u m P h o s p h o r u s C a C l C O 2 M g P h o s
- - 1 0 . 5 m g / d L
- 8 - 1 0 6 m E q / L
- 2 - 3 0 m E q / L
- . 5 - 2 . 5 m E q / L
- - 4 . 5 m E q / L
L I V E R F U N C T I O N T E S T ( L F T )
A l k a l i n e P h o s p h a t a s e B i l i r u b i n Aspartate aminotransferase Alanine aminotransferase L a c t i c d e h y d r o g e n a s e A m m o n i a P r o t e i n t o t a l A l b u m i n A L P B i l i
A S T / S G O T
A L T / S G P T
L D H N H 3 n / a n / a
3 0 - 1 2 0 I U / L
T o t a l : 0 . 3 - 1 m g / d L
I n d i r e c t : 0 . 2 - 0 . 8 m g / d L
D i r e c t : 0 . 1 - 0 . 3 m g / d L
0 - 3 5 I U / L
- - 3 6 I U / m L
1 0 0 - 1 9 0 I U / L
- 5 - 1 1 0 m c g / d L
- . 4 - 8 . 3 g / d L
- . 5 - 5 g / d L
L I P I D P A N E L
T r i g l y c e r i d e s H i g h D e n s i t y L i p o p r o t e i n L o w D e n s i t y L i p o p r o t e i n T r i g H D L L D L
M a l e : 4 0 - 1 6 0 m g / d L
F e m a l e : 3 5 - 1 3 5 m g / d L
M a l e : > 4 5 m g / d L
F e m a l e : > 5 5 m g / d L
< 1 3 0 m g / d L
P A N C R E A T I C E N Z Y M E S
A m y l a s e L i p a s e n / a n / a
5 6 - 1 9 0 I U / L
0 - 1 1 0 I U / L
TestAbbreviationValue
ADDITIONAL LAB VALUES FOR REFERENCE CONTINUED
T H Y R O I D P A N E L
Thyroid Stimulating Hormone S e r u m T h y r o x i n e S e r u m T r i i o d o t h y r o n i n e T S H T 4 T 3
- . 5 - 5 m i l l i - I U / L
- - 1 2 n g / d L
- 0 - 2 2 0 n g / d L
C A R D I A C
Creatinine phosphokinase C a r d i a c C e l l I s o e n z y m e Brain and Lung Cell Isoenzyme M y o g l o b i n T r o p o n i n I T r o p o n i n T B-Type Natriuretic Peptide C P K
C P K - M B
C P K - B B
n / a T I T T B N P
M a l e : 5 5 - 1 7 0 I U / L
F e m a l e : 3 0 - 1 3 5 I U / L
- %
- %
M a l e : 1 0 - 9 5 n g / m L
F e m a l e : 1 0 - 6 5 n g / m L
- - 0 . 1 n g / m L
- - 0 . 2 n g / m L
< 1 0 0 p g / m L
M I S C E L L A N E O U S
Erythrocyte Sedimentation Rate C - R e a c t i v e P r o t e i n I r o n Total iron binding capacity S e r u m O s m o l a l i t y Glomerular Filtration Rate O2 Content Base Excess E S R C R P n / a
T I B C
n / a G F R n / a n / a
Male: 15 mm/hr
Female: up to 20 mm/hr
< 1 . 0 m g / d L
Male: 80-180 mcg/dL
Female: 60-160 mcg/dL
- 5 0 - 4 6 0 m c g / d L
- 0 - 1 2 0 m L / m i n
- 5 - 2 0 v o l %
- ± 2 m E q / L
285-295 mOsm/kg H2O
U R I N E S T U D I E S
S p e c i f i c G r a v i t y A l b u m i n , P r o t e i n p H W h i t e B l o o d C e l l s U r i n e o s m o l a l i t y n / a n / a n / a W B C n / a
1 . 0 0 5 - 1 . 0 3 0
- 0 - 8 0 m g
4 . 6 - 8
- - 4
1 0 0 - 9 0 0
THERAPEUTIC DRUG
LEVELS
DrugTherapeutic range Toxic range D i g o x i n L i t h i u m V a l p r o i c A c i d C a r b a m a z e p i n e P h e n y t o i n T h e o p h y l l i n e L i d o c a i n e A c e t a m i n o p h e n A m i k a c i n G e n t a m i c i n V a n c o m y c i n
- . 5 - 2 n g / m L
- . 6 – 1 . 2 m E q / L
- 0 - 1 2 5 m c g / m L
- - 1 2 m c g / m L
- 0 - 2 0 m c g / m L
- 0 - 2 0 m c g / m L
- . 5 - 5 m c g / m L
- 5 - 2 5 m c g / m L
- - 1 0 m c g / m L
D e p e n d s o n u s e
P e a k: 2 0 - 4 0 m c g / m L
T r o u g h: 1 0 - 2 0 m c g / m L
> 2 . 2 n g / m L > 1 . 5 m E q / L > 1 2 5 m c g / m L > 1 2 m c g / m L > 3 0 m c g / m L > 2 0 m c g / m L > 5 m c g / m L > 2 5 0 m c g / m L > 2 5 m c g / m L > 1 2 m c g / m L > 4 0 m c g / m L